Tech Company Financing Transactions
Overture Life Funding Round
Overture Life secured a $57 million funding round on 4/24/2025. Backers included GV, Khosla Ventures and Overwater Ventures.
Transaction Overview
Company Name
Announced On
4/24/2025
Transaction Type
Venture Equity
Amount
$57,000,000
Round
Undisclosed
Investors
Proceeds Purpose
This new funding allows us to accelerate our expansion of IVF capabilities and demonstrates the value of operating within a CLIA-licensed laboratory environment, highlighting not only our technological leadership but also our commitment to the highest standards of clinical validation.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
117 East 57th St 27A
New York, NY 10022
USA
New York, NY 10022
USA
Phone
Website
Email Address
Overview
Overture Life is a biotechnology company specializing in automating in vitro fertilization (IVF) and embryology processes to enhance accessibility, affordability, and standardization in reproductive healthcare. Founded in 2017, the company has developed technologies like the "Naturalife" embryology mini-lab, which automates manual embryology tasks, including non-invasive genetic embryo testing, egg freezing, and embryo vitrification. These innovations aim to reduce disparities in success rates between fertility clinics and lower the cost of artificial insemination.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 4/24/2025: ALT Sports Data venture capital transaction
Next: 4/24/2025: Chassy venture capital transaction
Share this article
News on VC Transactions
We do our best to report on tech company VC transactions. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs